Union européenne -
français -
EMA (European Medicines Agency)
segluromet
merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - diabète sucré, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
segluromet 2.5 mg / 1000 mg comprimés pelliculés
msd merck sharp & dohme ag - ertugliflozinum, metformini hydrochloridum - comprimés pelliculés - ertugliflozinum 2,5 mg à ertugliflozini l-pidolas, metformini hydrochloridum 1000 mg, excipiens pro compresso de la brume. - le diabète sucré de type 2 - synthetika
Canada -
français -
Health Canada
segluromet comprimé
merck canada inc - ertugliflozine; chlorhydrate de metformine - comprimé - 2.5mg; 500mg - ertugliflozine 2.5mg; chlorhydrate de metformine 500mg - biguanides
Canada -
français -
Health Canada
segluromet comprimé
merck canada inc - ertugliflozine; chlorhydrate de metformine - comprimé - 2.5mg; 1000mg - ertugliflozine 2.5mg; chlorhydrate de metformine 1000mg - biguanides
Canada -
français -
Health Canada
segluromet comprimé
merck canada inc - ertugliflozine; chlorhydrate de metformine - comprimé - 7.5mg; 500mg - ertugliflozine 7.5mg; chlorhydrate de metformine 500mg - biguanides
Canada -
français -
Health Canada
segluromet comprimé
merck canada inc - ertugliflozine; chlorhydrate de metformine - comprimé - 7.5mg; 1000mg - ertugliflozine 7.5mg; chlorhydrate de metformine 1000mg - biguanides